From The Guardian
GSK shares dive as weaker sales and mounting costs unnerve investors
British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the...